Literature DB >> 33852540

COVID-19-Related Circumstances for Hospital Readmissions: A Case Series From 2 New York City Hospitals.

Justin J Choi1, Jigar H Contractor1, Amy L Shaw1, Youmna Abdelghany1, Jesse Frye1, Madelyn Renzetti1, Emily Smith1, Leland R Soiefer1, Shuting Lu2, Justin R Kingery1, Jamuna K Krishnan1, William J Levine1, Monika M Safford1, Martin F Shapiro1.   

Abstract

OBJECTIVE: The aim of the study was to determine the main factors contributing to hospital readmissions and their potential preventability after a coronavirus disease 2019 (COVID-19) hospitalization at 2 New York City hospitals.
METHODS: This was a retrospective study at 2 affiliated New York City hospitals located in the Upper East Side and Lower Manhattan neighborhoods. We performed case reviews using the Hospital Medicine Reengineering Network framework to determine potentially preventable readmissions among patients hospitalized for COVID-19 between March 3, 2020 (date of first case) and April 27, 2020, and readmitted to either of the 2 hospitals within 30 days of discharge.
RESULTS: Among 53 readmissions after hospitalization for COVID-19, 44 (83%) were deemed not preventable and 9 (17%) were potentially preventable. Nonpreventable readmissions were mostly due to disease progression or complications of COVID-19 (37/44, 84%). Main factors contributing to potentially preventable readmissions were issues with initial disposition (5/9, 56%), premature discharge (3/9, 33%), and inappropriate readmission (1/9, 11%) for someone who likely did not require rehospitalization.
CONCLUSIONS: Most readmissions after a COVID-19 hospitalization were not preventable and a consequence of the natural progression of the disease, specifically worsening dyspnea or hypoxemia. Some readmissions were potentially preventable, mostly because of issues with disposition that were directly related to challenges posed by the ongoing COVID-19 pandemic. Clinicians should be aware of challenges with disposition related to circumstances of the COVID-19 pandemic.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33852540      PMCID: PMC8131259          DOI: 10.1097/PTS.0000000000000870

Source DB:  PubMed          Journal:  J Patient Saf        ISSN: 1549-8417            Impact factor:   2.243


  25 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System.

Authors:  John P Donnelly; Xiao Qing Wang; Theodore J Iwashyna; Hallie C Prescott
Journal:  JAMA       Date:  2021-01-19       Impact factor: 56.272

3.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Authors:  D W Bates; D J Cullen; N Laird; L A Petersen; S D Small; D Servi; G Laffel; B J Sweitzer; B F Shea; R Hallisey
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

4.  Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.

Authors:  Jeffrey L Schnipper; Christianne L Roumie; Courtney Cawthon; Alexandra Businger; Anuj K Dalal; Ileko Mugalla; Svetlana Eden; Terry A Jacobson; Kimberly J Rask; Viola Vaccarino; Tejal K Gandhi; David W Bates; Daniel C Johnson; Stephanie Labonville; David Gregory; Sunil Kripalani
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-03

5.  Adverse drug events in ambulatory care.

Authors:  Tejal K Gandhi; Saul N Weingart; Joshua Borus; Andrew C Seger; Josh Peterson; Elisabeth Burdick; Diane L Seger; Kirstin Shu; Frank Federico; Lucian L Leape; David W Bates
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

6.  Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial.

Authors:  Sunil Kripalani; Christianne L Roumie; Anuj K Dalal; Courtney Cawthon; Alexandra Businger; Svetlana K Eden; Ayumi Shintani; Kelly Cunningham Sponsler; L Jeff Harris; Cecelia Theobald; Robert L Huang; Danielle Scheurer; Susan Hunt; Terry A Jacobson; Kimberly J Rask; Viola Vaccarino; Tejal K Gandhi; David W Bates; Mark V Williams; Jeffrey L Schnipper
Journal:  Ann Intern Med       Date:  2012-07-03       Impact factor: 25.391

7.  The incidence and severity of adverse events affecting patients after discharge from the hospital.

Authors:  Alan J Forster; Harvey J Murff; Josh F Peterson; Tejal K Gandhi; David W Bates
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

8.  Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19.

Authors:  Sulaiman S Somani; Felix Richter; Valentin Fuster; Jessica K De Freitas; Nidhi Naik; Keith Sigel; Erwin P Bottinger; Matthew A Levin; Zahi Fayad; Allan C Just; Alexander W Charney; Shan Zhao; Benjamin S Glicksberg; Anuradha Lala; Girish N Nadkarni
Journal:  J Gen Intern Med       Date:  2020-08-19       Impact factor: 5.128

9.  Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study.

Authors:  Oğuz Abdullah UyaroĞlu; Nursel Çalik BaŞaran; Lale ÖziŞik; Gülçİn Tellİ Dİzman; İmdat EroĞlu; Taha Koray Şahİn; Zahİt TaŞ; Ahmet Çağkan İnkaya; Mıne Durusu TanriÖver; Gökhan Metan; Gülay Saİn GÜven; Serhat Ünal
Journal:  Int J Qual Health Care       Date:  2021-02-20       Impact factor: 2.038

10.  Analysis of Risk Factors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data.

Authors:  Woo-Hwi Jeon; Jeong Yeon Seon; So-Youn Park; In-Hwan Oh
Journal:  Int J Environ Res Public Health       Date:  2020-08-12       Impact factor: 3.390

View more
  3 in total

1.  In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil.

Authors:  Hugo Perazzo; Sandra W Cardoso; Maria Pia D Ribeiro; Rodrigo Moreira; Lara E Coelho; Emilia M Jalil; André Miguel Japiassú; Elias Pimentel Gouvêa; Estevão Portela Nunes; Hugo Boechat Andrade; Luciano Barros Gouvêa; Marcel Treptow Ferreira; Pedro Mendes de Azambuja Rodrigues; Ronaldo Moreira; Kim Geraldo; Lucilene Freitas; Vinicius V Pacheco; Esau Custódio João; Trevon Fuller; Verônica Diniz Rocha; Ceuci de Lima Xavier Nunes; Tâmara Newman Lobato Souza; Ana Luiza Castro Conde Toscano; Alexandre Vargas Schwarzbold; Helena Carolina Noal; Gustavo de Araujo Pinto; Paula Macedo de Oliveira Lemos; Carla Santos; Fernanda Carvalho de Queiroz Mello; Valdilea G Veloso; Beatriz Grinsztejn
Journal:  Lancet Reg Health Am       Date:  2022-04-12

2.  Hospital readmissions and post-discharge all-cause mortality in COVID-19 recovered patients; A systematic review and meta-analysis.

Authors:  Zhian Salah Ramzi
Journal:  Am J Emerg Med       Date:  2021-11-06       Impact factor: 4.093

3.  COVID-19 Readmissions: Main Patient Characteristics.

Authors:  Carlos Kerguelen; Mariana Vasquez-Roldan; José de la Hoz-Valle
Journal:  J Patient Saf       Date:  2022-08-01       Impact factor: 2.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.